Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
News of the day
FDA Approves Drug for Patients with Advanced Prostate Cancer
December 29, 2008 -- The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. moreNovartis strengthens vaccine pipeline with agreement for novel CMV vaccines candidate
Basel, December 29, 2008 - Novartis has strengthened its vaccines pipeline through an exclusive agreement to license AlphaVax' investigational Cytomegalovirus (CMV) vaccine program. This CMV agreement adds to Novartis' promising early stage pipeline of novel vaccines, which focuses on significant unmet needs for the prevention of fatal diseases such as meningococcal infections and other hospital and community acquired infections. These include vaccines to prevent Helicobacter pylori infections,... moreActavis Totowa and FDA Reach Agreement on Consent Decree
December 29, 2008--Actavis Inc. today announced that it has reached agreement on a Consent Decree of Permanent Injunction with the Food and Drug Administration (FDA) regarding the company's Actavis Totowa LLC subsidiary. This agreement, in effect, settles the issues identified by the Department of Justice in its previously filed complaint against Actavis Inc., Actavis Totowa, and officers Sigurdur Oli Olafsson and Douglas Boothe. moreIndustry news search
Most Viewed News
- Zealand Pharma and Helsinn Healthcare Sign a Partnering Agreement for ZP1846, a novel GLP-2 agonistH
- VALEANT TO ACQUIRE DOW PHARMACEUTICAL SCIENCES, INC
- EXONHIT LAUNCHES MOUSE GENOME SPLICEARRAYTM FOR USE IN HUMAN DISEASE MODELING STUDIES
- MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone & joint disease
- HELSINN HEALTHCARE AND ZEALAND PHARMA SIGN A PARTNERING AGREEMENT FOR ZP1846, A NOVEL GLP-2 AGONIST
- RSS Feed...
Latest news by category
Deals and Alliances
- Actavis Totowa and FDA Reach Agreement on Consent Decree
- Novartis strengthens vaccine pipeline with agreement for novel CMV vaccines candidate
- U.S. Federal Trade Commission Provisionally Accepts Consent Decree and Terminates Waiting Period for King Pharmaceuticals' Acquisition of Alpharma
- More news...
Development
- Product Development Update: Intercell starts Phase II clinical trial for Pseudomonas aeruginosa vaccine and FDA approval of IXIARO
- King Pharmaceuticals Initiates Phase II Clinical Trial Evaluating T-62 as a Treatment for Neuropathic Pain
- Dr. Reddy's Laboratories announce settlement of Clarinex
- More news...
Company releases
- Novo Nordisk will remain the dominant player in the metabolic drug market in 2014 while Merck will raise its ranking with Januvia
- New Technology Aims to Reduce Maternal and Neonatal Deaths
- Most important factors driving usage of antibiotics in the ICU setting are availability in intravenous formulation, activity against key gram negative pathogens, drug interactions and bactericidal act
- More news...
Deals review
- HELSINN HEALTHCARE AND ZEALAND PHARMA SIGN A PARTNERING AGREEMENT FOR ZP1846, A NOVEL GLP-2 AGONIST
- 50 million dollar export deal for signed with Russia's largest pharmaceutical company
- Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
- More news...
PR Newswire
- MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
- Frost & Sullivan Lauds SonoScape's Outstanding Entrepreneurship
- German Appeals Court Rules in Favor of AGA Medical in Patent Infringement Lawsuit Against Occlutech
- More news...
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us